GSK3B and myocardial infarction: Another study demonstrated that in a murine model of MI, the deletion in cardiac fibroblasts exacerbated fibrosis and left ventricular dysfunction by enhancing TGF‐β1/SMAD‐3 signaling, [14] thus indicating that GSK3β might be a promising molecular target for the management of atrial fibrosis and remodeling.